| Jessica K Schreck, PA | |
|
7200 W Bell Rd, Bldg A, Glendale, AZ 85308-8529 | |
| (623) 487-4822 | |
| (623) 334-9881 |
| Full Name | Jessica K Schreck |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 12 Years |
| Location | 7200 W Bell Rd, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013254226 | NPI | - | NPPES |
| 5338 | Other | AZ | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 5338 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Western Regional Medical Center | Goodyear, AZ | Hospital |
| Banner - University Medical Center Phoenix | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ctca Physicians Group Of Arizona Llc | 2264593474 | 100 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.
At first, the teacher described her six-year-old student as absentminded, a daydreamer. The boy was having difficulty paying attention in class. As the teacher watched the boy closely, she realized that he was not daydreaming. He often blanked out for a few seconds and wouldn't respond when she called his name. On occasion, he would blink a lot and his eyes would roll up.
The Beryl Institute released a report highlighting results from its recent patient experience benchmarking study conducted in collaboration with Catalyst Healthcare Research, an independent marketing research firm.
In the May 15th issue of G&D, Dr. Michael Carey (UCLA's Jonsson Comprehensive Cancer Center) and colleagues lend new insight into the mechanism of epigenetic silencing of euchromatic genes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica K Schreck, PA 1760 E River Rd, Ste. # 350, Tucson, AZ 85718-5877 Ph: (520) 519-7775 | Jessica K Schreck, PA 7200 W Bell Rd, Bldg A, Glendale, AZ 85308-8529 Ph: (623) 487-4822 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.
At first, the teacher described her six-year-old student as absentminded, a daydreamer. The boy was having difficulty paying attention in class. As the teacher watched the boy closely, she realized that he was not daydreaming. He often blanked out for a few seconds and wouldn't respond when she called his name. On occasion, he would blink a lot and his eyes would roll up.
The Beryl Institute released a report highlighting results from its recent patient experience benchmarking study conducted in collaboration with Catalyst Healthcare Research, an independent marketing research firm.
In the May 15th issue of G&D, Dr. Michael Carey (UCLA's Jonsson Comprehensive Cancer Center) and colleagues lend new insight into the mechanism of epigenetic silencing of euchromatic genes.
› Verified 5 days ago
Tiffani Rollins, P.A.-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 5601 W Eugie Ave, 106, Glendale, AZ 85304 Phone: 602-978-6255 Fax: 602-564-9286 | |
Michelle W Sedlacek, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 6320 W Union Hills Dr, Bldg B #2600, Glendale, AZ 85308 Phone: 602-942-5600 Fax: 623-825-6386 | |
Castillanna Nicole Loya Jaffe, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 5310 W Thunderbird Rd Ste 301, Glendale, AZ 85306 Phone: 602-865-4441 | |
Mrs. Samadhy Ruiz, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5750 W. Thunderbird Ave, Suite B- 200, Glendale, AZ 85306 Phone: 602-375-1700 Fax: 602-843-2847 | |
Ms. Katherine Lijoi, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 16390 N 59th Ave Ste 200, Glendale, AZ 85306 Phone: 623-334-4000 Fax: 623-334-4400 | |
Paige Richardson Holyoak, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 20100 N 51st Ave, F620, Glendale, AZ 85308 Phone: 623-376-6328 Fax: 623-566-6454 |